Free Trial

Precipio (PRPO) Competitors

Precipio logo
$24.04 +1.56 (+6.94%)
Closing price 04:00 PM Eastern
Extended Trading
$24.14 +0.10 (+0.42%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PRPO vs. OWLT, QTRX, KEQU, SEER, and RPID

Should you buy Precipio stock or one of its competitors? MarketBeat compares Precipio with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Precipio include Owlet (OWLT), Quanterix (QTRX), Kewaunee Scientific (KEQU), Seer (SEER), and Rapid Micro Biosystems (RPID). These companies are all part of the "measuring and control equipment" industry.

How does Precipio compare to Owlet?

Owlet (NYSE:OWLT) and Precipio (NASDAQ:PRPO) are both small-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, media sentiment, valuation and dividends.

72.6% of Owlet shares are owned by institutional investors. Comparatively, 10.5% of Precipio shares are owned by institutional investors. 52.2% of Owlet shares are owned by insiders. Comparatively, 16.6% of Precipio shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Precipio has lower revenue, but higher earnings than Owlet. Precipio is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$105.70M1.36-$39.68M-$3.07N/A
Precipio$24.05M1.79-$360K-$0.47N/A

Owlet has a beta of 1.85, indicating that its stock price is 85% more volatile than the broader market. Comparatively, Precipio has a beta of 1.3, indicating that its stock price is 30% more volatile than the broader market.

Precipio has a net margin of -3.57% compared to Owlet's net margin of -42.54%. Owlet's return on equity of 0.00% beat Precipio's return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-42.54% N/A -18.02%
Precipio -3.57%-6.73%-4.49%

In the previous week, Precipio had 4 more articles in the media than Owlet. MarketBeat recorded 4 mentions for Precipio and 0 mentions for Owlet. Precipio's average media sentiment score of 0.26 beat Owlet's score of 0.00 indicating that Precipio is being referred to more favorably in the news media.

Company Overall Sentiment
Owlet Neutral
Precipio Neutral

Owlet presently has a consensus target price of $20.00, indicating a potential upside of 304.29%. Given Owlet's stronger consensus rating and higher probable upside, equities research analysts plainly believe Owlet is more favorable than Precipio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Precipio
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Owlet beats Precipio on 9 of the 16 factors compared between the two stocks.

How does Precipio compare to Quanterix?

Precipio (NASDAQ:PRPO) and Quanterix (NASDAQ:QTRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings and profitability.

Precipio has higher earnings, but lower revenue than Quanterix. Precipio is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precipio$24.05M1.79-$360K-$0.47N/A
Quanterix$138.90M1.20-$107.15M-$2.36N/A

Precipio has a beta of 1.3, indicating that its stock price is 30% more volatile than the broader market. Comparatively, Quanterix has a beta of 1.14, indicating that its stock price is 14% more volatile than the broader market.

Quanterix has a consensus price target of $4.00, indicating a potential upside of 13.31%. Given Quanterix's stronger consensus rating and higher possible upside, analysts plainly believe Quanterix is more favorable than Precipio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precipio
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Quanterix
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

10.5% of Precipio shares are held by institutional investors. Comparatively, 86.5% of Quanterix shares are held by institutional investors. 16.6% of Precipio shares are held by company insiders. Comparatively, 1.5% of Quanterix shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Precipio has a net margin of -3.57% compared to Quanterix's net margin of -71.86%. Precipio's return on equity of -6.73% beat Quanterix's return on equity.

Company Net Margins Return on Equity Return on Assets
Precipio-3.57% -6.73% -4.49%
Quanterix -71.86%-23.92%-17.66%

In the previous week, Precipio had 1 more articles in the media than Quanterix. MarketBeat recorded 4 mentions for Precipio and 3 mentions for Quanterix. Quanterix's average media sentiment score of 0.93 beat Precipio's score of 0.26 indicating that Quanterix is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Precipio
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Quanterix
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Precipio beats Quanterix on 9 of the 15 factors compared between the two stocks.

How does Precipio compare to Kewaunee Scientific?

Precipio (NASDAQ:PRPO) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap measuring and control equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability, media sentiment and institutional ownership.

Kewaunee Scientific has a net margin of 3.85% compared to Precipio's net margin of -3.57%. Kewaunee Scientific's return on equity of 18.09% beat Precipio's return on equity.

Company Net Margins Return on Equity Return on Assets
Precipio-3.57% -6.73% -4.49%
Kewaunee Scientific 3.85%18.09%6.71%

10.5% of Precipio shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 16.6% of Precipio shares are held by company insiders. Comparatively, 13.3% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Precipio had 2 more articles in the media than Kewaunee Scientific. MarketBeat recorded 4 mentions for Precipio and 2 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 0.93 beat Precipio's score of 0.26 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Precipio
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Kewaunee Scientific
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Precipio has a beta of 1.3, indicating that its share price is 30% more volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.7, indicating that its share price is 30% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precipio
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Kewaunee Scientific has higher revenue and earnings than Precipio. Precipio is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precipio$24.05M1.79-$360K-$0.47N/A
Kewaunee Scientific$240.47M0.47$11.40M$3.7210.63

Summary

Kewaunee Scientific beats Precipio on 10 of the 14 factors compared between the two stocks.

How does Precipio compare to Seer?

Seer (NASDAQ:SEER) and Precipio (NASDAQ:PRPO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, media sentiment, institutional ownership and valuation.

Seer presently has a consensus price target of $4.00, indicating a potential upside of 115.05%. Given Seer's stronger consensus rating and higher probable upside, equities research analysts plainly believe Seer is more favorable than Precipio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Seer
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
3.00
Precipio
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

75.2% of Seer shares are owned by institutional investors. Comparatively, 10.5% of Precipio shares are owned by institutional investors. 11.3% of Seer shares are owned by insiders. Comparatively, 16.6% of Precipio shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Precipio has higher revenue and earnings than Seer. Precipio is trading at a lower price-to-earnings ratio than Seer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Seer$16.58M6.17-$73.60M-$1.24N/A
Precipio$24.05M1.79-$360K-$0.47N/A

Precipio has a net margin of -3.57% compared to Seer's net margin of -464.78%. Precipio's return on equity of -6.73% beat Seer's return on equity.

Company Net Margins Return on Equity Return on Assets
Seer-464.78% -26.58% -23.51%
Precipio -3.57%-6.73%-4.49%

In the previous week, Seer had 1 more articles in the media than Precipio. MarketBeat recorded 5 mentions for Seer and 4 mentions for Precipio. Seer's average media sentiment score of 1.16 beat Precipio's score of 0.26 indicating that Seer is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Seer
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Precipio
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Seer has a beta of 1.59, meaning that its share price is 59% more volatile than the broader market. Comparatively, Precipio has a beta of 1.3, meaning that its share price is 30% more volatile than the broader market.

Summary

Seer beats Precipio on 9 of the 16 factors compared between the two stocks.

How does Precipio compare to Rapid Micro Biosystems?

Rapid Micro Biosystems (NASDAQ:RPID) and Precipio (NASDAQ:PRPO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk and institutional ownership.

Rapid Micro Biosystems presently has a consensus target price of $6.00, indicating a potential upside of 206.12%. Given Rapid Micro Biosystems' stronger consensus rating and higher possible upside, research analysts clearly believe Rapid Micro Biosystems is more favorable than Precipio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rapid Micro Biosystems
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Precipio
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

52.6% of Rapid Micro Biosystems shares are owned by institutional investors. Comparatively, 10.5% of Precipio shares are owned by institutional investors. 12.7% of Rapid Micro Biosystems shares are owned by company insiders. Comparatively, 16.6% of Precipio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Precipio has a net margin of -3.57% compared to Rapid Micro Biosystems' net margin of -145.81%. Precipio's return on equity of -6.73% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Rapid Micro Biosystems-145.81% -131.52% -67.48%
Precipio -3.57%-6.73%-4.49%

In the previous week, Rapid Micro Biosystems had 1 more articles in the media than Precipio. MarketBeat recorded 5 mentions for Rapid Micro Biosystems and 4 mentions for Precipio. Precipio's average media sentiment score of 0.26 beat Rapid Micro Biosystems' score of 0.23 indicating that Precipio is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rapid Micro Biosystems
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Precipio
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Precipio has lower revenue, but higher earnings than Rapid Micro Biosystems. Precipio is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rapid Micro Biosystems$33.59M2.69-$47.12M-$1.12N/A
Precipio$24.05M1.79-$360K-$0.47N/A

Rapid Micro Biosystems has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market. Comparatively, Precipio has a beta of 1.3, meaning that its share price is 30% more volatile than the broader market.

Summary

Rapid Micro Biosystems beats Precipio on 9 of the 16 factors compared between the two stocks.

Get Precipio News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRPO vs. The Competition

MetricPrecipioMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$40.18M$1.57B$6.47B$12.54B
Dividend YieldN/AN/A2.69%5.22%
P/E Ratio-51.1577.6222.3924.18
Price / Sales1.796.92520.79112.26
Price / Cash28.2922.8741.3457.13
Price / Book2.894.779.846.72
Net Income-$360K-$54.76M$3.57B$337.19M
7 Day Performance2.08%-0.78%-1.16%0.48%
1 Month Performance-22.30%4.20%3.85%5.07%
1 Year Performance126.37%-3.40%27.40%34.25%

Precipio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRPO
Precipio
0.713 of 5 stars
$24.04
+6.9%
N/A+106.2%$40.18M$24.05MN/A60
OWLT
Owlet
2.6962 of 5 stars
$5.72
-0.2%
$20.00
+249.7%
-15.2%$165.77M$107.06MN/A106
QTRX
Quanterix
1.9806 of 5 stars
$2.62
-2.4%
$4.00
+53.0%
-33.3%$123.18M$144.74MN/A460
KEQU
Kewaunee Scientific
1.514 of 5 stars
$40.11
+0.4%
N/A+4.5%$115.12M$240.47M10.781,239
SEER
Seer
3.6154 of 5 stars
$1.89
+0.8%
$4.00
+112.2%
-12.6%$103.70M$14.68MN/A160

Related Companies and Tools


This page (NASDAQ:PRPO) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners